Online
|
|
gsk pharma
Posted by :
phirozabanIn which year the last Bonus issue was done by this Company. Not at least in last 12 years, I believe....
gsk pharma
Posted by :
GuestNo changes in the Directorate will have any effect except a BONUS ISSUE THAT TOO VERY LIBERAL...
NSE Announcements on GlaxoSmithKline
Posted by : MMB MessengerGlaxosmithkline Pharmaceuticals Limited has informed the Exchange regarding the following changes in the Directorate with effect from July 27, 2009: 1) Mr. D. Sundaram has been appointed as an Independent Non-Executive Director in the casual vacancy caused by the resignation of Dr. Mark Reilly. 2) Mr. Ajit Nimbalkar has been appointed as an Additional Independent Non-Executive Director. 3) Mr. Peter Bains has resigned as a Director of the Company....
BSE Announcements on GlaxoSmithKline
Posted by : MMB Messenger
GlaxoSmithKline Pharmaceuticals Ltd has informed BSE about the following changes in the Directorate with effect from July 27, 2009:
1. Mr. D Sundaram has been appointed as an Independent Non-Executive Director in the casual vacancy caused by the resignation of Dr. Mark Reilly.
2. Mr. Ajit Nimbalkar has been appointed as an Additional Independent Non-Executive Director.
3. Mr. Peter Bains has resigned as a Director of the Company....
NSE Announcements on GlaxoSmithKline
Posted by : MMB MessengerGlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding the standalone Results for the half year ended on 30-JUN-2009 as follows: Net Sales of Rs. 91456 lacs for half year ending on 30-JUN-2009 against Rs. 83501 lacs for the half year ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 26762 lacs for the half year ending on 30-JUN-2009 against Rs. 23613 lacs for the half year ending on 30-JUN-2008....
NSE Announcements on GlaxoSmithKline
Posted by : MMB MessengerGlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 45741 lacs for quarter ending on 30-JUN-2009 against Rs. 41690 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 12435 lacs for the quarter ending on 30-JUN-2009 against Rs. 11486 lacs for the quarter ending on 30-JUN-2008....
BSE Announcements on GlaxoSmithKline
Posted by : MMB Messenger
GlaxoSmithKline Pharmaceuticals Ltd has announced the following Unaudited results for the quarter ended June 30, 2009:
The Company has posted a net profit of Rs 1243.50 million for the quarter ended June 30, 2009 as compared to Rs 1148.60 million for the quarter ended June 30, 2008. Total Income has increased from Rs 4282.60 million for the quarter ended June 30, 2008 to Rs 4799.50 million for the quarter ended June 30, 2009....
gsk pharma
Posted by : Guestwill this tumble today as the news is out of shantha biotech which is taken over by Sanofi, Even the Meriux Alliance has been taken over by Sanofi. GSK PHARMA IS LEFT HIGH AND DRY DOING NOTHING ...
BONUS CANDIDATES
Posted by :
cd
CHECK IT OUT:
GLAXO (PHARMA), GRASIM, MONSANTO:
HIGH PRICES, HIGH EPS, HUGE RESERVES = BONUS CANDATES...
gsk pharma
Posted by : Guestthis company which always keeps news a secret, may come out with news of shanta biotech buyout whether its correct or a rumour and also clear about the purchase of Steifel labs in India has also clicked or not. lets keep guessing....
BSE Announcements on GlaxoSmithKline
Posted by : MMB MessengerGlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on July 27, 2009, inter alia, to consider approval of unaudited financial results for the 2nd quarter April - June 2009(Q2) & Half-year ended June 30, 2009....
gsk pharma
Posted by : GuestSince the 2nd quarter results are round corner, possibilities of a surprise is always there. moreover the outcome of the shanta biotech buyout by GSK pharma will be bursted out, who always keep news as a secret...
gsk pharma
Posted by : Guestyes - the higher ups in GSK pharma has to seriosly think about bonus share issue....
gsk pharma
Posted by : GuestGSK India (pharmaceuticals) a thorough bonus candidate in all respects, provided the higher management also thinks in the same manner....
